Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 989472

Targeting tumour metastasis: the emerging role of nanotechnology


Visentin, Sarah; Sedić, Mirela; Kraljević Pavelić, Sandra; Pavelić, Krešimir
Targeting tumour metastasis: the emerging role of nanotechnology // Current medicinal chemistry, 27 (2020), 8; 1367-1381 doi:10.2174/0929867326666181220095343 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 989472 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Targeting tumour metastasis: the emerging role of nanotechnology

Autori
Visentin, Sarah ; Sedić, Mirela ; Kraljević Pavelić, Sandra ; Pavelić, Krešimir

Izvornik
Current medicinal chemistry (0929-8673) 27 (2020), 8; 1367-1381

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
cancer stem cells ; cancer therapy ; metastasis ; nanomedicine ; stem cell marker

Sažetak
Metastatic process has still not been completely elucidated, probably due to insufficient knowledge of the underlying mechanisms. Here, we provide an overview of the current findings that shed light on specific molecular alterations associated with metastasis and present novel concepts in the treatment of the metastatic process. In particular, we discuss novel pharmacological approaches in the clinical setting that target metastatic progression. New insights into the process of metastasis allow optimizing and designing new treatment strategies, especially when taking into account the fact that metastatic cells share common features with stem cells. Lastly, we touch upon nano- and micro-technologies in targeted drug delivery for metastatic cancer. The latter could provide more efficient way to tackle metastasis and thus bring about advancements in the treatment and management of cancer patients.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Sveučilište Jurja Dobrile u Puli,
Sveučilište u Rijeci - Odjel za biotehnologiju

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov europepmc.org

Citiraj ovu publikaciju:

Visentin, Sarah; Sedić, Mirela; Kraljević Pavelić, Sandra; Pavelić, Krešimir
Targeting tumour metastasis: the emerging role of nanotechnology // Current medicinal chemistry, 27 (2020), 8; 1367-1381 doi:10.2174/0929867326666181220095343 (međunarodna recenzija, članak, znanstveni)
Visentin, S., Sedić, M., Kraljević Pavelić, S. & Pavelić, K. (2020) Targeting tumour metastasis: the emerging role of nanotechnology. Current medicinal chemistry, 27 (8), 1367-1381 doi:10.2174/0929867326666181220095343.
@article{article, author = {Visentin, Sarah and Sedi\'{c}, Mirela and Kraljevi\'{c} Paveli\'{c}, Sandra and Paveli\'{c}, Kre\v{s}imir}, year = {2020}, pages = {1367-1381}, DOI = {10.2174/0929867326666181220095343}, keywords = {cancer stem cells, cancer therapy, metastasis, nanomedicine, stem cell marker}, journal = {Current medicinal chemistry}, doi = {10.2174/0929867326666181220095343}, volume = {27}, number = {8}, issn = {0929-8673}, title = {Targeting tumour metastasis: the emerging role of nanotechnology}, keyword = {cancer stem cells, cancer therapy, metastasis, nanomedicine, stem cell marker} }
@article{article, author = {Visentin, Sarah and Sedi\'{c}, Mirela and Kraljevi\'{c} Paveli\'{c}, Sandra and Paveli\'{c}, Kre\v{s}imir}, year = {2020}, pages = {1367-1381}, DOI = {10.2174/0929867326666181220095343}, keywords = {cancer stem cells, cancer therapy, metastasis, nanomedicine, stem cell marker}, journal = {Current medicinal chemistry}, doi = {10.2174/0929867326666181220095343}, volume = {27}, number = {8}, issn = {0929-8673}, title = {Targeting tumour metastasis: the emerging role of nanotechnology}, keyword = {cancer stem cells, cancer therapy, metastasis, nanomedicine, stem cell marker} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font